Large-Scale Recombinant Antibody Production

Release time: 2024-11-05 View volume: 65

Case Study:

Utilizing AtaGenix's proprietary XtenCHO^TM mammalian expression system, we successfully expressed full-length IgG, VHH, scFv, and Fab antibody fragments.

Antibody Expression SDS-PAGE Analysis Using XtenCHO

Lane MW: Protein Marker; Lane 1: Reduced SDS-PAGE; Lane 2: Non-reduced SDS-PAGE.

Support Center

Resource Downloads
Case Studies
Research Publishing
Media Hub
FAQs
Publication Insights

Messages

By Method

By Application

Large-Scale Recombinant Antibody Production

About us

Core Technologies

Resource Center